Fortrea Holdings Inc. (FTRE)
NASDAQ: FTRE · Real-Time Price · USD
17.65
-0.06 (-0.34%)
At close: Jun 26, 2026, 4:00 PM EDT
17.69
+0.04 (0.23%)
After-hours: Jun 26, 2026, 5:53 PM EDT
Fortrea Holdings Revenue
Fortrea Holdings had revenue of $636.50M in the quarter ending March 31, 2026, a decrease of -2.27%. This brings the company's revenue in the last twelve months to $2.71B, up 0.86% year-over-year. In the year 2025, Fortrea Holdings had annual revenue of $2.72B with 1.00% growth.
Revenue (ttm)
$2.71B
Revenue Growth
+0.86%
P/S Ratio
0.62
Revenue / Employee
$193,471
Employees
14,000
Market Cap
1.67B
Revenue Chart
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 2.72B | 27.00M | 1.00% |
| Dec 31, 2024 | 2.70B | -27.00M | -0.99% |
| Dec 31, 2023 | 2.72B | 27.00M | 1.00% |
| Dec 31, 2022 | 2.70B | -146.10M | -5.14% |
| Dec 31, 2021 | 2.84B | 262.20M | 10.16% |
| Dec 31, 2020 | 2.58B | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Innoviva | 420.69M |
| Maravai LifeSciences Holdings | 204.73M |
| UroGen Pharma | 140.49M |
| Zymeworks | 81.26M |
| Septerna | 72.26M |
| Vir Biotechnology | 65.50M |
| Mesoblast | 65.38M |
| Zenas BioPharma | 10.00M |
FTRE News
- 2 days ago - Fortrea CFO Jill McConnell to step down, Jason Knoblauch to succeed - TheFly
- 2 days ago - Fortrea Names Jason Knoblauch as Chief Financial Officer - GlobeNewsWire
- 4 days ago - Fortrea price target raised to $18 from $16 at Barclays - TheFly
- 17 days ago - Fortrea Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4) - GlobeNewsWire
- 19 days ago - Fortrea Holdings Transcript: AGM 2026 - Transcripts
- 24 days ago - Fortrea Holdings Transcript: Jefferies Global Healthcare Conference 2026 - Transcripts
- 25 days ago - Fortrea to Attend Jefferies Global Healthcare Conference - GlobeNewsWire
- 6 weeks ago - Fortrea price target raised to $13 from $11 at Mizuho - TheFly